Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock

Acute myocardial infarction (AMI) resulting in cardiogenic shock continues to be a substantial source of morbidity and mortality despite advances in recognition and treatment. Prior to the advent of percutaneous and more durable left ventricular support devices, prompt revascularization with the add...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Pratik K., Mertens, Amy, Shah, Dinesh, Hanson, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364115/
https://www.ncbi.nlm.nih.gov/pubmed/30809398
http://dx.doi.org/10.1155/2019/4591250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364115/
https://www.ncbi.nlm.nih.gov/pubmed/30809398
http://dx.doi.org/10.1155/2019/4591250

Ejemplares similares